These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 26551085)

  • 1. Induction of CYP2E1 in non-alcoholic fatty liver diseases.
    Aljomah G; Baker SS; Liu W; Kozielski R; Oluwole J; Lupu B; Baker RD; Zhu L
    Exp Mol Pathol; 2015 Dec; 99(3):677-81. PubMed ID: 26551085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alcohol, microbiome, life style influence alcohol and non-alcoholic organ damage.
    Neuman MG; French SW; Zakhari S; Malnick S; Seitz HK; Cohen LB; Salaspuro M; Voinea-Griffin A; Barasch A; Kirpich IA; Thomes PG; Schrum LW; Donohue TM; Kharbanda KK; Cruz M; Opris M
    Exp Mol Pathol; 2017 Feb; 102(1):162-180. PubMed ID: 28077318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translational Implications of the Alcohol-Metabolizing Enzymes, Including Cytochrome P450-2E1, in Alcoholic and Nonalcoholic Liver Disease.
    Song BJ; Akbar M; Jo I; Hardwick JP; Abdelmegeed MA
    Adv Pharmacol; 2015; 74():303-72. PubMed ID: 26233911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pioglitazone, quercetin and hydroxy citric acid effect on cytochrome P450 2E1 (CYP2E1) enzyme levels in experimentally induced non alcoholic steatohepatitis (NASH).
    Surapaneni KM; Priya VV; Mallika J
    Eur Rev Med Pharmacol Sci; 2014; 18(18):2736-41. PubMed ID: 25317811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The discovery of the microsomal ethanol oxidizing system and its physiologic and pathologic role.
    Lieber CS
    Drug Metab Rev; 2004 Oct; 36(3-4):511-29. PubMed ID: 15554233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis.
    Weltman MD; Farrell GC; Hall P; Ingelman-Sundberg M; Liddle C
    Hepatology; 1998 Jan; 27(1):128-33. PubMed ID: 9425928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binge alcohol consumption aggravates oxidative stress and promotes pathogenesis of NASH from obesity-induced simple steatosis.
    Minato T; Tsutsumi M; Tsuchishima M; Hayashi N; Saito T; Matsue Y; Toshikuni N; Arisawa T; George J
    Mol Med; 2014 Dec; 20(1):490-502. PubMed ID: 25180626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of reactive oxygen species (ROS) and cytochrome P-450 2E1 in the generation of carcinogenic etheno-DNA adducts.
    Linhart K; Bartsch H; Seitz HK
    Redox Biol; 2014; 3():56-62. PubMed ID: 25462066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of cytochrome CYP2E1 as critical mediator of synergistic effects of alcohol and cellular lipid accumulation in hepatocytes in vitro.
    Mahli A; Thasler WE; Patsenker E; Müller S; Stickel F; Müller M; Seitz HK; Cederbaum AI; Hellerbrand C
    Oncotarget; 2015 Dec; 6(39):41464-78. PubMed ID: 26497211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relevance of CYP2E1 to non-alcoholic fatty liver disease.
    Daly AK
    Subcell Biochem; 2013; 67():165-75. PubMed ID: 23400921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alcohol Metabolism in the Progression of Human Nonalcoholic Steatohepatitis.
    Li H; Toth E; Cherrington NJ
    Toxicol Sci; 2018 Aug; 164(2):428-438. PubMed ID: 29718361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic lipid peroxidation and cytochrome P-450 2E1 in pediatric nonalcoholic fatty liver disease and its subtypes.
    Bell LN; Molleston JP; Morton MJ; Klipsch A; Saxena R; Vuppalanchi R; Chalasani N
    J Clin Gastroenterol; 2011 Oct; 45(9):800-7. PubMed ID: 21602702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term treatment with alcohols causes hepatic steatosis and enhances acetaminophen hepatotoxicity in Cyp2e1(-/-) mice.
    Sinclair JF; Szakacs JG; Wood SG; Walton HS; Bement JL; Gonzalez FJ; Jeffery EH; Wrighton SA; Bement WJ; Sinclair PR
    Toxicol Appl Pharmacol; 2000 Oct; 168(2):114-22. PubMed ID: 11032766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nrf2 and antioxidant defense against CYP2E1 toxicity.
    Cederbaum A
    Expert Opin Drug Metab Toxicol; 2009 Oct; 5(10):1223-44. PubMed ID: 19671018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-alcoholic fatty liver disease (NAFLD) - pathogenesis, classification, and effect on drug metabolizing enzymes and transporters.
    Cobbina E; Akhlaghi F
    Drug Metab Rev; 2017 May; 49(2):197-211. PubMed ID: 28303724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of a cytochrome P450 2E1 transgenic mouse and initial evaluation of alcoholic liver damage.
    Morgan K; French SW; Morgan TR
    Hepatology; 2002 Jul; 36(1):122-34. PubMed ID: 12085356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal CYP2E1: A mediator of alcohol-induced gut leakiness.
    Forsyth CB; Voigt RM; Keshavarzian A
    Redox Biol; 2014; 3():40-6. PubMed ID: 25462064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel pathway for iron deficiency in pediatric non-alcoholic steatohepatitis.
    Moya D; Baker SS; Liu W; Garrick M; Kozielski R; Baker RD; Zhu L
    Clin Nutr; 2015 Jun; 34(3):549-56. PubMed ID: 25000850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variations of superoxide dismutase 2 and cytochrome P450 2E1 in non-alcoholic steatohepatitis.
    Huang YS; Chang CH; Lin TL; Perng CL
    Liver Int; 2014 Jul; 34(6):931-6. PubMed ID: 24649902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased apolipoprotein A5 expression in human and rat non-alcoholic fatty livers.
    Feng Q; Baker SS; Liu W; Arbizu RA; Aljomah G; Khatib M; Nugent CA; Baker RD; Forte TM; Hu Y; Zhu L
    Pathology; 2015 Jun; 47(4):341-8. PubMed ID: 25938357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.